Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2005
09/20/2005US6945247 Method of treating cardio pulmonary diseases with no group compounds
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085241A1 Thiazole derivative
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005084702A1 Agent for preventing and treating organ fibrosis
09/15/2005WO2005084693A1 Extract of hippophae rhamnoides seed
09/15/2005WO2005084679A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
09/15/2005WO2005084657A1 Compositions and methods for preventing or treating an inflammatory response
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2004018465A9 Benzonaphthyridines with pde 3/4 inhibiting activity
09/15/2005US20050203158 Substituted benzimidazole compounds
09/15/2005US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203112 Bicyclic amides
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203107 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203068 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
09/15/2005US20050203061 Produrg which can reduce side effects of drug by utilizing an enzyme whose enzymatic activity has difference between target site of drug and site to express side effects; a glycosidase, for example, beta -glucuronidase, may be used as enzyme; salbutamol is an example of the drug
09/15/2005US20050202048 Chlamydia antigens and vaccine uses of the protein
09/15/2005US20050202013 Novel Th2-specific molecules and uses thereof
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases)
09/15/2005US20050201980 Method for short-term and long-term drug dosimetry
09/15/2005US20050201950 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
09/15/2005US20050201947 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005DE102004008375A1 Use of synergistic combination of ascorbate and a sympathomimetic for topical treatment of inflammation of respiratory mucosa, particularly where caused by viral infection
09/15/2005CA2558262A1 Rnai-based therapeutics for allergic rhinitis and asthma
09/14/2005EP1574501A1 Quinolinone derivatives, pharmaceutical compositions containing them and their use
09/14/2005EP1573450A2 System and method for transparent early detection, warning, and intervention during a medical procedure
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572876A2 Transcriptional regulation of target genes
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572739A1 Asthma susceptibility locus
09/14/2005EP1572684A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572683A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572650A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
09/14/2005EP1572648A1 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
09/14/2005EP1572622A1 Levalbuterol salt
09/14/2005EP1572217A1 Combination medicament
09/14/2005EP1572208A2 Method for counteracting a pathologic change in the beta-adrenergic pathway
09/14/2005EP1572202A2 Use of serotonin receptor antagonists for the treatment of sleep apnea
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572177A1 Compositions and methods for treating upper respiratory congestion
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572075A2 Method for treating diseases associated with abnormal kinase activity
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668600A 5-substituted isoquinoline derivatives
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668316A Anti-spasmodic comprising xenon
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668289A Modafinil pharmaceutical compositions
09/14/2005CN1666992A Medical use of catalpol and its homologs
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666769A Pharmaceutical composition for treating lung-heat disease and preparation method thereof
09/14/2005CN1666760A Medicine for treating chicken respiratory tract disease
09/14/2005CN1666737A Application of citric acid solution in preparation of antiphlogistic drug
09/14/2005CN1219044C Cough-relieving wine
09/14/2005CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218730C Traditional Chinese medicine for treating chronic trachitis, and method for preparing same
09/14/2005CN1218725C Medicament compsn. for curing acute pharyngitis and its preparation method
09/14/2005CN1218719C Drug for treating cough
09/14/2005CN1218718C Medication for bronchial asthma and chronic bronchitis , and its preparation method
09/14/2005CN1218705C Anti SARS virus medicine and synthesizing method thereof
09/14/2005CN1218691C Dual-layer slow releasing tablet of benproperine phosphate
09/13/2005US6943253 6-phenylpyrrolopyrimidinedione derivatives
09/13/2005US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
1 ... 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 ... 878